分析代谢综合征患者的焦虑、抑郁和肥胖之间的关联。

Q3 Medicine
Endocrine regulations Pub Date : 2023-05-15 Print Date: 2023-01-01 DOI:10.2478/enr-2023-0011
Jamile das Virgens Silva, Claubert Radames O Coutinho-Lima, Najara Amaral Brandao, Luama Araujo Dos Santos, Vanessa Cristina Dias, Aiala Brito Correa, Daniela Oliveira de Almeida, Gildasio Conceicao, Thais Costa Machado Florence, Amanda Galvao de Almeida, Edilene Maria Queiroz Araujo
{"title":"分析代谢综合征患者的焦虑、抑郁和肥胖之间的关联。","authors":"Jamile das Virgens Silva, Claubert Radames O Coutinho-Lima, Najara Amaral Brandao, Luama Araujo Dos Santos, Vanessa Cristina Dias, Aiala Brito Correa, Daniela Oliveira de Almeida, Gildasio Conceicao, Thais Costa Machado Florence, Amanda Galvao de Almeida, Edilene Maria Queiroz Araujo","doi":"10.2478/enr-2023-0011","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective.</b> The aim of this study was to verify the association between anxiety, depression, and obesity in metabolic syndrome (MetS) patients. <b>Methods.</b> It is a retrospective study with 142 volunteers with MetS of both genders and age ≥20 years. Every subject responded to the hospital anxiety and depression scale (HADS). Data are shown as absolute and relative frequencies for categorical variables and a Pearson's chi-square test was performed to verify the association between anxiety or depression and body mass index (BMI). The value of p≤0.05 was considered to be statistically significant. <b>Results.</b> The frequency of anxiety and depression was 18.3% (n=26) and 12% (n=17), respectively. There was no significant association between anxiety or depression and BMI (p=0.481 and 0.079, respectively) in individuals with MetS. <b>Conclusions.</b> Although no association among anxiety, depression and obesity was found, the psychological factors should be added to the MetS treatment contributing to a more effective health care in order to find answers to manage and adhere to the conducts carried out from a more humanized and transdisciplinary perspective. The data also indicate that large sample and case-control methodology are required to obtain a more specific evaluation of this association.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"57 1","pages":"92-98"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of the association between anxiety, depression and obesity in individuals with metabolic syndrome.\",\"authors\":\"Jamile das Virgens Silva, Claubert Radames O Coutinho-Lima, Najara Amaral Brandao, Luama Araujo Dos Santos, Vanessa Cristina Dias, Aiala Brito Correa, Daniela Oliveira de Almeida, Gildasio Conceicao, Thais Costa Machado Florence, Amanda Galvao de Almeida, Edilene Maria Queiroz Araujo\",\"doi\":\"10.2478/enr-2023-0011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective.</b> The aim of this study was to verify the association between anxiety, depression, and obesity in metabolic syndrome (MetS) patients. <b>Methods.</b> It is a retrospective study with 142 volunteers with MetS of both genders and age ≥20 years. Every subject responded to the hospital anxiety and depression scale (HADS). Data are shown as absolute and relative frequencies for categorical variables and a Pearson's chi-square test was performed to verify the association between anxiety or depression and body mass index (BMI). The value of p≤0.05 was considered to be statistically significant. <b>Results.</b> The frequency of anxiety and depression was 18.3% (n=26) and 12% (n=17), respectively. There was no significant association between anxiety or depression and BMI (p=0.481 and 0.079, respectively) in individuals with MetS. <b>Conclusions.</b> Although no association among anxiety, depression and obesity was found, the psychological factors should be added to the MetS treatment contributing to a more effective health care in order to find answers to manage and adhere to the conducts carried out from a more humanized and transdisciplinary perspective. The data also indicate that large sample and case-control methodology are required to obtain a more specific evaluation of this association.</p>\",\"PeriodicalId\":11650,\"journal\":{\"name\":\"Endocrine regulations\",\"volume\":\"57 1\",\"pages\":\"92-98\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine regulations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2478/enr-2023-0011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine regulations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/enr-2023-0011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"Print","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

研究目的本研究旨在验证代谢综合征(MetS)患者的焦虑、抑郁和肥胖之间的关联。研究方法这是一项回顾性研究,研究对象为 142 名患有代谢综合征的志愿者,男女不限,年龄均≥20 岁。每位受试者都对医院焦虑抑郁量表(HADS)做出了回答。数据显示为分类变量的绝对频率和相对频率,并通过皮尔逊卡方检验来验证焦虑或抑郁与体重指数(BMI)之间的关联。P≤0.05 的值被认为具有统计学意义。结果焦虑和抑郁的发生率分别为 18.3%(26 人)和 12%(17 人)。在 MetS 患者中,焦虑或抑郁与体重指数之间没有明显关联(P=0.481 和 0.079)。结论。虽然没有发现焦虑、抑郁与肥胖之间的关联,但应在 MetS 治疗中加入心理因素,以促进更有效的医疗保健,从而找到从更人性化和跨学科的角度管理和坚持治疗的答案。这些数据还表明,需要采用大样本和病例对照方法来对这种关联进行更具体的评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Analysis of the association between anxiety, depression and obesity in individuals with metabolic syndrome.

Objective. The aim of this study was to verify the association between anxiety, depression, and obesity in metabolic syndrome (MetS) patients. Methods. It is a retrospective study with 142 volunteers with MetS of both genders and age ≥20 years. Every subject responded to the hospital anxiety and depression scale (HADS). Data are shown as absolute and relative frequencies for categorical variables and a Pearson's chi-square test was performed to verify the association between anxiety or depression and body mass index (BMI). The value of p≤0.05 was considered to be statistically significant. Results. The frequency of anxiety and depression was 18.3% (n=26) and 12% (n=17), respectively. There was no significant association between anxiety or depression and BMI (p=0.481 and 0.079, respectively) in individuals with MetS. Conclusions. Although no association among anxiety, depression and obesity was found, the psychological factors should be added to the MetS treatment contributing to a more effective health care in order to find answers to manage and adhere to the conducts carried out from a more humanized and transdisciplinary perspective. The data also indicate that large sample and case-control methodology are required to obtain a more specific evaluation of this association.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Endocrine regulations
Endocrine regulations Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.70
自引率
0.00%
发文量
33
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信